|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Animal Health | Boehringer Ingelheim | Pfizer Inc. |
| Part of divestiture aftermath of Pfizer's acquisition of Wyeth and the antitrust approval process. Boehringer Ingelheim will acquire cattle and more... | ||
| Animal Health | Sanofi-Aventis | Merial Limited |
| Merial is a 50/50 joint venture between Merck and Sanofi-Aventis. The combination would create a new leader in this $19b global animal health more... | ||
| Biopharmaceuticals | Abbott Laboratories | Solvay Pharmaceuticals |
| Provides Abbott with a large portfolio of pharmaceutical products and a significant presence in key global emerging markets (Eastern Europe and more... | ||
| Biopharmaceuticals | Absorption Systems, LP | Perry Scientific, Inc. |
| Perry’s services complement Absorption Systems’ portfolio of products and services, which provide data regarding the absorption, more... | ||
| Biopharmaceuticals | Alcon, Inc. | ESBATech AG |
| ESBATech has proprietary single-chain antibody fragment technology for topical and local drug delivery presenting opportunities in ophthalmology. more... | ||
| Biopharmaceuticals | Arcion Therapeutics, Inc. | Anesiva, Inc. |
| Takes Arciion public combining a pipeline of late-stage programs addressing neuropathic pain, moderate-to-severe osteoarthritis and post-operative more... | ||
| Biopharmaceuticals | Biovail Corporation | Santhera |
| In its 3rd significant purchase for central nervous system treatments, Biovail gets a drug to treat dyskinesia in Parkinson's disease. The more... | ||
| Biopharmaceuticals | Bristol-Myers Squibb Company | Medarex, Inc. |
| Represents another important step in BMY's transformation to a pure biopharma company, after shedding its wound-care and medical-imaging units, more... | ||
| Biopharmaceuticals | CombinatoRx, Incorporated | Neuromed Pharmaceuticals, Inc. |
| Stock for stock merger which seeks savings and synergies by combining 2 drug development programs -- Neuromed's drug development expertise, with more... | ||
| Biopharmaceuticals | Dainippon Sumitomo Pharma Co., Ltd. | Sepracor Inc. |
| Accelerates DSP’s plan to globalize; provides a U.S./Canada platform with an experienced management team and talented employee base; allows DSP more... | ||
| Biopharmaceuticals | Hisamitsu Pharmaceutical Co., Inc. | Noven Pharmaceuticals, Inc. |
| Expands Hisamitsu's US presence and presents the opportunity to build upon Noven’s capabilities in transdermal drug development, more... | ||
| Biopharmaceuticals | Johnson & Johnson | Elan Corporation |
| J&J enters the high-stakes race to find new medicines for Alzheimer's disease by paying $1.5b for a 18.5% stake in Elan, which has had a more... | ||
| Biopharmaceuticals | Johnson & Johnson Inc. | Crucell NV |
| J&J buys an 18% stake for $440m to gain access to the development of a universal flu vaccine, made from "monoclonal antibodies" — which more... | ||
| Biopharmaceuticals | LEO Pharma A/S | Peplin, Inc. |
| Fortifies LEO's global dermatology position. Peplin's lead candidate, PEP005 Gel for actinic keratosis (precancerous growth on the skin), is more... | ||
| Biopharmaceuticals | Ligand Pharmaceuticals Incorporated | Neurogen Corporation |
| Ligand gains access to a partnership with Merck (for Vanilloid Receptor Subtype 1 Antagonists -- for sleep disorders), additional pipeline assets and more... | ||
| Biopharmaceuticals | Lion Holdings Inc. | Life Sciences Research Inc. |
| LSR provides product development services to pharmaceutical, biotechnology and agrochemical companies. This is a new platform for buyout firm Lion more... | ||
| Biopharmaceuticals | MediciNova Inc. | Avigen Inc. |
| Both companies are running clinical trials of a drug candidate called ibudilast, although for different indications: Avigen for chronic nerve pain, more... | ||
| Biopharmaceuticals | Taisho Pharmaceutical Co., Ltd | Bristol-Myers Squibb |
| This planned divestiture is a part of Bristol-Myers Squibb's strategic transformation into a more focused biopharma company. It sold its Japan more... | ||
| Biopharmaceuticals | Valeant Pharmaceuticals International | Tecnofarma S.A. de C.V. |
| Complements Valeant Mexico's current market focus on the commercial branded generic market. Adds 2 well-established businesses, a new pipeline of more... | ||
| Biopharmaceuticals | Warner Chilcott plc | The Procter & Gamble Company |
| The deal includes P&G's portfolio of branded drugs, a blockbuster osteoporosis treatment and urology and gastroenterology treatments. This more... | ||
| Data Management/ Healthcare IT | Dell Inc. | Perot Systems Corporation |
| Marks a major move by Dell into computer services and an entre into the healthcare market in advance of Dell's introduction of its electronic more... | ||
| Data Management/ Healthcare IT | Merge Healthcare Incorporated | Confirma, Inc. |
| Confirma is the largest privately-held developer of CAD software for medical imaging. The deal brings Confirma’s technologies to Merge’s more... | ||
| Data Management/ Healthcare IT | PeriGen, Inc. | LMS Medical Systems Ltd. |
| Integrates LMS’s suite of advanced fetal strip monitoring and interpretative solutions with PeriBirth’s clinical decision support system. more... | ||
| Data Management/ Healthcare IT | Phase Forward | Maaguzi LLC |
| Extends Phase Forward’s clinical research suite into observational studies markets. Clinical studies are progressively incorporating data more... | ||
| Dental | Zila Inc. | Tolmar Inc. |
| Combines two dental products companies focused on consumable home care products, in-office diagnostics, acute care products, and dental prevention more... | ||
| Diagnostics | Agilent Technologies Inc. | Varian, Inc. |
| A major step in Agilent’s transformation into a leading bio-analytical measurement company to augment its position in electronic measurement. more... | ||
| Diagnostics | Cell Biosciences, Inc. | Alpha Innotech Corporation |
| Creates a bigger protein analysis business with both traditional and novel protein analysis. Alpha makes instruments, reagents and bioinformatics more... | ||
| Diagnostics | Corning Incorporated | Axygen BioScience Inc |
| Axygen sells high-quality plastic consumables (pipettes, pipette tips, and high-throughput screening (HTS) products) and lab equipment (centrifuges, more... | ||
| Diagnostics | Danaher Corporation | MDS Inc. and Life Technologies Corp |
| With this and a related deal, Danaher is buying 100% ownership (from 2 sources) of AB SCIEX, a major manufacturer of mass spectrometers selling into more... | ||
| Diagnostics | Dionex, Inc. | Magellan Biosciences, Inc. |
| The sale enables Magellan to focus on clinical-diagnostic systems and tests designed for doctors. Dionex adds 3 category-leading HPLC detector more... | ||
| Diagnostics | ICON plc | Veeda Laboratories Ltd |
| Expands ICON’s biomarker and immunoassay capabilities in Europe. Veeda Laboratories is a specialist provider of biomarker laboratory services more... | ||
| Diagnostics | Millipore Corporation | BioAnaLab |
| Enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position as a preferred outsource partner more... | ||
| Diagnostics | PerkinElmer, Inc. | SYM-BIO Lifescience |
| SYM-BIO is a major Chinese supplier of diagnostics for infectious diseases, a major addition to PerkinElmer. The acquisition doubles more... | ||
| Diagnostics | QIAGEN N.V. | DxS Ltd. |
| QIAGEN strengthens its position in personalized healthcare (PHC). The combined company is active in over 15 collaborations with pharmaceutical more... | ||
| Diagnostics | Thermo Fisher Scientific Inc. | B.R.A.H.M.S. AG |
| B.R.A.H.M.S.' specialty in-vitro diagnostic tests are based on patented biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as more... | ||
| Medical Devices | Abbott Laboratories | Visiogen, Inc. |
| Provides Abbott with a new accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients. Visiogen's IOL is more... | ||
| Medical Devices | Abbott Laboratories | Evalve Inc. |
| After owning 10% of Evalve, Abbott buys the entire company for its minimally invasive mitral-valve repair technology. Traditionally mitral more... | ||
| Medical Devices | Aurora Capital Group | HLTH Corporation |
| Porex produces porous plastic products used in healthcare, industrial and consumer applications. Porex does not fit with WebMD, but represents a more... | ||
| Medical Devices | Cardinal Health, Inc. | Biotech |
| Cardinal already operates 160 nuclear pharmacies and 26 cyclotron-based PET radiopharmaceutical manufacturing facilities, which manufacture PET more... | ||
| Medical Devices | Cortec Group | 180 Medical, Inc. |
| Represents a new platform for Cortec. 180 Medical sells over 500 types of urologic catheters directly to patients with spinal cord injuries, spina more... | ||
| Medical Devices | Cortec Group | Katena Products, Inc. |
| Represents a new platform. Katena is a leading producer of precision hand-held surgical instruments and disposables and has been in the forefront in more... | ||
| Medical Devices | Covidien | Aspect Medical Systems, Inc. |
| Adds a market leading brain monitoring technology and expands Covidien's presence in the OR. Aspect’s premier product — Bispectral more... | ||
| Medical Devices | Covidien Ltd. | Power Medical Interventions, Inc. |
| PMI’s powered stapling platform, the SurgAssist, has been used in more than 45,000 procedures globally. It recently introduced wireless more... | ||
| Medical Devices | Current Solutions, LLC | Koalaty Products, Inc. |
| In addition to innovative TENS units, Koalaty distributes electrodes, orthopedic pillows, braces, batteries and topical analgesics. Pain management more... | ||
| Medical Devices | Davol Inc. | Brennen Medical, LLC |
| The hernia mesh product line employs proprietary porcine dermal matrix technology for enhanced biocompatibility. The line augments Davol's more... | ||
| Medical Devices | Embla Systems | Covidien Ltd. |
| The combined entity will form the world’s largest company to focus entirely on sleep diagnostics, with close to 1,700 customers in North America more... | ||
| Medical Devices | ICU Medical, Inc. | Hospira, Inc. |
| Positions ICU to improve gross margins and earnings by vertically integrating; it had been manufacturing the majority of Hospira's critical care more... | ||
| Medical Devices | Integra LifeSciences Holdings Corporation | Innovative Spinal Technologies, Inc. |
| Assets acquired include a system for percutaneous lumbar fusion procedures, an anterior cervical plating system, several product development assets, more... | ||
| Medical Devices | IntriCon Corporation | Datrix, Inc |
| Datrix makes Holter monitors and equipment for electrocardiograph (ECG) management systems with Wi-Fi capability. The handheld ECG stores information more... | ||
| Medical Devices | Lake Region Medical, Ltd | Brivant Medical |
| Both companies are OEM leaders for medical device guidewires and related products for minimally-invasive cardiac surgery and other procedures. Lake more... | ||
| Medical Devices | Natus Medical Incorporated | Alpine Biomed Holdings Corp |
| Expands Natus' international presence and neurological offerings and leverages its sales force and distribution networks. Alpine has advanced more... | ||
| Medical Devices | PuriCore | Misonix Inc. |
| Labcaire is a U.K. supplier and manufacturer of endoscope disinfection equipment and air filtration systems, and fits with PuriCore's focus. more... | ||
| Medical Devices | Royal Philips Electronics | Cardium Therapeutics Inc. |
| Adds to Philips' emergency medicine portfolio. InnerCool manages a patient’s body temperature (therapeutic hypothermia) during and after a more... | ||
| Medical Devices | Syneron Medical Ltd. | Candela Corporation |
| This stock merger combines two medical laser technology providers for aesthetic treatments such as hair removal, wrinkle reduction, acne treatment more... | ||
| Medical Devices | Synovis Life Technologies Inc. | Pegasus Biologics Inc. |
| Gives Synovis access to growing orthopedic and wound care markets. Synovis plans to market the new products via sales people recruited from the more... | ||
| Medical Devices | Wound Management Technologies, Inc. | BioPharma Management Technologies, Inc. |
| BioPharma's technologies are complementary to Wound Management's major product CellerateRx®, a collagen hydrolysate polypeptid used to more... | ||
| Medical Devices | Wound Management Technologies, Inc. | Resorbable Orthopedics LLC |
| Adds complementary orthopedic biomaterials products to WMT's portfolio. The target has a patented bone wax and delivery system addressing ‘bone more... | ||
| Medical Services | Inverness Medical Innovations, Inc. | Free & Clear, Inc. |
| Dovetails with Inverness' growing consumer diagnostic product line and Alere disease management unit. Deal value -- $100m, plus $30m of more... | ||
| Medical Services | Transcend Services Inc. | Medical Dictation Services, Inc. |
| MDI has approximately 450 employees providing service to approximately 30 customers located in the mid-Atlantic region. A synergistic deal. Value more... | ||
| OTC/Consumer | Abbott Laboratories | Wockhardt Limited and Carol Info Services Limited |
| Wockhardt has a significant presence in India's pediatric and adult nutrition segments with infant formulas, weaning foods and adult protein more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||